bpc-157 subcutaneous vs intramuscular administration Injectable Healing Peptide Site Injection Instructional Video w/ John Tsikouris bpc-157 injection subcutaneous vs intramuscular

Its a handy reference if youre a visual learner

Most supportive claims rely on BPC-157 experiments in rats or isolated tendon cells, combined with studies of full-length thymosin beta-4

The vials are independent and can be handled as separate reference standards

While BPC-157 isn't a muscle-building peptide, its tissue repair properties may support the musculoskeletal system during the metabolic stress of caloric restriction and rapid weight change

No clinical trial has tested the exact combination, but the closely related CagriSema (cagrilintide + semaglutide) Phase 3 trial showed that adding amylin to a GLP-1 backbone improves weight loss